http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102503930-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a6f422b091ba12ea61d4adbf1b0e8e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
filingDate 2011-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4f032eebbf050fd3cecfe3d09d6f1cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36867a152348c5b846a4f44c198272a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf7e8115c1271dd573ae8d840602ed55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_debb3841e57d642e6ea654c202d46107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_791e0fa60d87220d9db758e22a9212ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec7ec98ac80c52e1e2710664bf14378d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4171336af12ae96cba2bdc15ca54d827
publicationDate 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102503930-A
titleOfInvention 3,4,5,-Trisubstituted aminothiophene compounds and their preparation and use
abstract The invention provides a class of 3,4,5,-trisubstituted aminothiophene compounds, which use substituted benzene as a raw material to obtain 3,4,5 ,-Trisubstituted aminothiophene derivatives. The compounds and their salts provided by the present invention have been proved by pharmacological experiments to have obvious effects on blocking p53-MDM2 interaction, and have significant in vitro proliferation inhibitory activity on tumor cells, with IC 50 reaching μM level. The invention has reasonable design, wide sources of raw materials, simple and convenient preparation method, mild reaction conditions, high yield in each step, is suitable for practical use, and can be used in the preparation of antitumor drugs; the general structural formula of the invention is: .
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114560843-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114560843-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110170054-A
priorityDate 2011-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011023677-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006074262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102066365-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466656185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467687257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466211203

Total number of triples: 33.